US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

308.33

-8.8700-2.80%

Post-market: 308.330.00000.00%16:00 EDT

Volume:352.66K

Turnover:107.06M

Market Cap:655.04M

PE:- -

High:315.40

Open:314.79

Low:293.00

Close:317.20

52wk High:341.93

52wk Low:66.60

Shares:2.12M

Float Shares:2.12M

Volume Ratio:0.70

T/O Rate:16.60%

Dividend:1.02

Dividend Rate:0.33%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval

Benzinga Earnings

New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe

Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

Press Release: Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights

Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Health Investors (NHI) and NorthWest Healthcare Properties REIT (OtherNWHUF)

Bernstein Keeps Their Buy Rating on Humana (HUM)

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)

BTIG Remains a Buy on Cerus (CERS)

OUE Healthcare (Catalist:5WA) Stock Faces Widening Losses As Speculation Builds

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial

Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)

Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade

Simply Wall St.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)

Analysts Offer Insights on Healthcare Companies: Kyntra Bio (KYNB) and Minerva Neurosciences (NERV)

Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":308.33,"timestamp":1787601600000,"preClose":317.2,"halted":0,"volume":352664,"hourTrading":{"tag":"盘后","latestPrice":308.33,"preClose":308.33,"latestTime":"16:00 EDT","volume":6,"amount":1849.98,"timestamp":1787601610755,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.027963430012610355,"floatShares":2124486,"shares":2124486,"eps":0,"marketStatus":"Post-Mkt","change":-8.87,"latestTime":"08-24 16:03:02 EDT","open":314.79,"high":315.4,"low":293,"amount":107061624,"amplitude":0.070618,"askPrice":311.2,"askSize":200,"bidPrice":307.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":317.2,"sharesOutstanding":3074486,"nav":316.946,"aum":673347221.03,"dividendRate":0.003292,"bidAskSpread":0.002803,"preHourTrading":{"tag":"盘前","latestPrice":314.59,"preClose":317.2,"latestTime":"09:25 EDT","volume":1055,"amount":335012.8868,"timestamp":1787577900633,"change":-2.61,"changeRate":-0.008228,"amplitude":0.020255},"postHourTrading":{"tag":"盘后","latestPrice":308.33,"preClose":308.33,"latestTime":"16:00 EDT","volume":6,"amount":1849.98,"timestamp":1787601610755,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.696512,"impliedVol":0.9682,"impliedVolPercentile":0.749},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2124486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.696512,"shares":2124486,"dividePrice":1.015,"high":315.4,"amplitude":0.070618,"preClose":317.2,"low":293,"week52Low":66.6,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":308.33,"eps":0,"divideRate":0.003292,"volume":352664,"delay":0,"ttmEps":0,"open":314.79,"prevYearClose":159.39,"prevWeekClose":317.2,"prevMonthClose":227.4,"prevQuarterClose":292.1,"fiveDayClose":287.3,"twentyDayClose":246.27,"sixtyDayClose":191.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659442411","title":"Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2659442411","media":"Benzinga Earnings","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659442411?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:25","pubTimestamp":1786713933,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics highlights Deramiocel&#39;s FDA review, commercial readiness, and cash position of $approximately $237.9 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/08/61208545/capricor-therapeutics-remains-optimistic-about-deramiocel-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","LABU","BK4585","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144253","title":"New Century Healthcare Flags Bank Account Freeze Linked to Partner Probe","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144253?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:12","pubTimestamp":1786713156,"startTime":"0","endTime":"0","summary":"The latest update is out from New Century Healthcare Holding Co. Ltd. ( ($HK:1518) ). New Century Healthcare disclosed that in late April 2026 some...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/new-century-healthcare-flags-bank-account-freeze-linked-to-partner-probe?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/new-century-healthcare-flags-bank-account-freeze-linked-to-partner-probe?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","CNBKA","HCSG","XBI","XLV","BK4588","LU0128526141.USD","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144391","title":"Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4D Molecular Therapeutics (FDMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144391?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:00","pubTimestamp":1786712444,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dogwood Therapeutics (DWTX), Talphera (TLPH) and 4...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dogwood-therapeutics-dwtx-talphera-tlph-and-4d-molecular-therapeutics-fdmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dogwood-therapeutics-dwtx-talphera-tlph-and-4d-molecular-therapeutics-fdmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DWTX","LABU","BK4581","XLV","BK4139","BK4588","XBI","TLPH","HCSG","BK4585","FDMT","LU0128526141.USD","LU0029874061.USD","BK4137","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659992141","title":"Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659992141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659992141?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:40","pubTimestamp":1786711234,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alumis-inc-alms-cabaletta-bio-caba-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alumis-inc-alms-cabaletta-bio-caba-and-capricor-therapeutics-capr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4007","BK4588","CABA","XLV","ALMS","BK4581","CAPR","BK4139","LABU","XBI","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659914159","title":"Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659914159","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659914159?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:32","pubTimestamp":1786710720,"startTime":"0","endTime":"0","summary":"Exploratory analyses of patients with very severe social anxiety disorder demonstrated nominally statistically significant improvement in recently reported clinical studies FDA engagement planned duri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345334/0/en/vistagen-reports-fiscal-year-2027-first-quarter-financial-results-and-corporate-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IND","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659614134","title":"Press Release: Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659614134","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659614134?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:30","pubTimestamp":1786710600,"startTime":"0","endTime":"0","summary":"-- Clene expects to submit a New Drug Application for CNM-Au8 in ALS. under the accelerated approval pathway in early fourth quarter of 2026. -- Clene announces survival and functional benefit in CNM-Au8-treated","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089279066.USD","LU1923621640.USD","BK4585","LU2125910336.SGD","LU2229751404.USD","BK4539","LABU","CNM","LU2125910179.SGD","BK4139","CLNN","BK4232","BK4588","R","BK4104","IE0009354923.USD","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659314135","title":"Press Release: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659314135","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659314135?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:30","pubTimestamp":1786710600,"startTime":"0","endTime":"0","summary":"-- Receives FDA Conditional Approval of QYLEKI(TM) as the Proposed Brand Name for QRX003 for Netherton Syndrome-- Reports Positive Clinical Update from Ongoing Pediatric Compassionate Use Program in N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","QNRX","TM","LABU","BK4555","03160","BK4604","BK4139","BK4099","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149444","title":"Analysts Offer Insights on Real Estate Companies: Equinix (EQIX), National Health Investors (NHI) and NorthWest Healthcare Properties REIT (OtherNWHUF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149444?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:20","pubTimestamp":1786710055,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on Equinix (EQIX), National Health Investors (NHI) and NorthWest He...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-equinix-eqix-national-health-investors-nhi-and-northwest-healthcare-properties-reit-othernwhuf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-real-estate-companies-equinix-eqix-national-health-investors-nhi-and-northwest-healthcare-properties-reit-othernwhuf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NHI","IYR","FRI","IVRA","RWO","PSR","BBRE","DFRA","USRT","MDIV","FREL","REAI","HCSG","URE","DPRE","EQIX","PPTY","XBI","ERET","IVEP","VNQ","PSCF","RJMG","IDGT","AVRE","WTRE","YLDW","LABU","REIX","REET","SPRE","BYRE","DFGR","REIT","XLRE","SCHH","JRE","ICF","XLV","DFAR","DTCR","CRED","RWR","IQRA","IYRI","JPRE","SRVR","BPRE","TRUR","VGSR","RNTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149469","title":"Bernstein Keeps Their Buy Rating on Humana (HUM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149469","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149469?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:18","pubTimestamp":1786709904,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes maintained a Buy rating on Humana today and set a price target of $425.00. Wilkes covers the Healthcare sector, focu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-keeps-their-buy-rating-on-humana-hum-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0070302665.USD","XBI","HUM","LU0390134368.USD","LU0266013472.USD","LU1983260115.SGD","BK4154","BK4566","BK4581","LU0417517546.SGD","BK4533","SG9999014005.SGD","LU1093756325.SGD","BK4585","BK4588","IHF","LU0320765489.SGD","LU1093756168.USD","SG9999014013.SGD","LU0208291251.USD","LU0170899867.USD","FXH","LABU","SG9999014021.USD","XLV","LU0256863811.USD","LU0238689110.USD","LU0211331839.USD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659149886","title":"Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Relay Therapeutics (RLAY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659149886","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659149886?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708866,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mediwound (MDWD) and Relay Therapeutics (RLAY) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-relay-therapeutics-rlay-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mediwound-mdwd-and-relay-therapeutics-rlay-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","RLAY","XLV","BK4139","BK4563","LABU","LU0128526141.USD","XBI","BK4581","BK4137","MDWD","BK4007","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146599","title":"BTIG Remains a Buy on Cerus (CERS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146599","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146599?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:36","pubTimestamp":1786707378,"startTime":"0","endTime":"0","summary":"In a report released today, Mark Massaro from BTIG reiterated a Buy rating on Cerus, with a price target of $4.00. Massaro covers the Healthcare se...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-cerus-cers-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","CERS","XBI","BK4198","LABU","BK4585","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659144729","title":"OUE Healthcare (Catalist:5WA) Stock Faces Widening Losses As Speculation Builds","url":"https://stock-news.laohu8.com/highlight/detail?id=2659144729","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659144729?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:32","pubTimestamp":1786707174,"startTime":"0","endTime":"0","summary":"OUE Healthcare’s stock has been on a speculative tear in recent months, yet it closed at just S$0.039 on Friday as investors absorbed another loss making half. The headline is not revenue; the story is the profit squeeze. H1 2026 revenue sat at S$75.21m, but the company reported a net loss of S$15.23m that widened sharply versus the prior year period and pulled trailing 12 month losses to S$29.66m.\nToday’s muted price suggests the market is still more captivated by the cheap P/S tag than by...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice1-main-header/1585186824821"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/healthcare/catalist-5wa/oue-healthcare-shares/news/oue-healthcare-catalist5wa-stock-faces-widening-losses-as-sp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/healthcare/catalist-5wa/oue-healthcare-shares/news/oue-healthcare-catalist5wa-stock-faces-widening-losses-as-sp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["5WA.SI","BK4585","BK6092","BK6511","LJ3.SI","BK4588","LABU","BK6098","XLV","XBI","BK6512","BK4581","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659128145","title":"Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Caribou Biosciences (CRBU) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659128145","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659128145?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:20","pubTimestamp":1786706410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharvaris (PHVS), Caribou Biosciences (CRBU) and Ave...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-caribou-biosciences-crbu-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4196","AVAH","BK4139","LABU","XBI","BK4581","CRBU","PHVS","BK4007","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659450421","title":"Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2659450421","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659450421?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"First patient dosed in an outpatient setting, discharged the same day; multiple patients in the process of screening at several activated sites Trial advances FT819 toward a potential accelerated regu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345223/24675/en/fate-therapeutics-initiates-potentially-registrational-reclaim-ln-clinical-trial-of-ft819-for-the-treatment-of-lupus-nephritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","CAR","BK4022","BK4077","BK4139","GDOC","MEDX","FATE","NVIB","BK4230","HYLG","IDNA","SLE","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145865","title":"Press Release: Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145865","media":"Dow Jones","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145865?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"US$9.5 million as of June 30, 2026, increased from US$4.1 million as of. -- Cash and cash equivalents nearly doubled to US$3.65 million, up from. -- Total shareholders' equity increased to US$6.09 million, up approximately. 19% from US$5.10 million at December 31, 2025, reflecting a strengthened. -- Working capital improved significantly to approximately US$1.66 million. as of June 30, 2026, up from approximately US$0.42 million at December. 31, 2025, indicating strengthened short-term liquidity and full coverage. -- Quick ratio of 1.19 as of June 30, 2026, compared to 1.06 as of December. divided by current liabilities), confirming robust liquidity even on a. December 31, 2025. Importantly, approximately 47% of current liabilities,items, reflecting the Company's strong balance sheet management.Reduced Cash Burn and Cost Discipline-- Total operating expenses decreased by 53% in the second quarter of 2026. compared to the same period in 2025, to US$2.29 million from US$4.85. -- General ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EQR","KBWB","LCIZ","LU2264538146.SGD","LU1244550221.USD","LU2357305700.SGD","LU0390134368.USD","LU1548497426.USD","LU0912757837.SGD","LU0006306889.USD","IND","BK4596","LU1244550494.USD","TM","LCDL","LU0234570918.USD","03160","LCID","LU2089283258.USD","REZ","BK4551","LU0098860793.USD","LU1791710400.SGD","BK4581","LU0210528500.USD","LU1732800096.USD","LU2023251221.USD","BK4516","BK4585","LU2133065610.SGD","LU0314104364.USD","LU1989772923.USD","IAI","LU0158827948.USD","LU1732799900.SGD","LU0053666078.USD","LABU","BK4127","LU1244550577.SGD","LU2111349929.HKD","BK4099","LU0106261372.USD","LU1791710582.SGD","LU0795875169.SGD","LU1988902786.USD","LU0267386448.USD","VMRK","QNTM","LU0106831901.USD","IE00B775SV38.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414358","title":"Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414358","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414358?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:40","pubTimestamp":1786704009,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mdxhealth-mdxh-opko-health-opk-and-zenas-biopharma-inc-zbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4581","MDXH","LU0029874061.USD","BK4588","XLV","HCSG","XBI","BK4139","BK4137","LU0128526141.USD","OPK","LABU","ZBIO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659417051","title":"Distinct Healthcare Holdings (SEHK:2677) Stock Looks Cheap Until One Off Gains Fade","url":"https://stock-news.laohu8.com/highlight/detail?id=2659417051","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659417051?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:22","pubTimestamp":1786702929,"startTime":"0","endTime":"0","summary":"Distinct Healthcare Holdings went into this earnings print with a stock that has drifted over the past quarter, down about 10% over 30 days, and only marginally higher over the past week. The headline this time is earnings quality. Reported profit over the last year includes a sizeable one off gain of C¥108.0m, which flatters both earnings per share and the headline P/E of 9.8x against a higher Hong Kong healthcare sector average. The market is now deciding how much of that apparent value in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2677/distinct-healthcare-holdings-shares/news/distinct-healthcare-holdings-sehk2677-stock-looks-cheap-unti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2677/distinct-healthcare-holdings-shares/news/distinct-healthcare-holdings-sehk2677-stock-looks-cheap-unti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RGLO","LU0128526141.USD","VGFPF","JOYT","DECU","LU0029874061.USD","FEBU","BK4588","BK4585","XBI","02677","XLV","HCSG","LABU","GXDW","BK4137","BK1209","BK4581","VOTE","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117015","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrodinger (SDGR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117015?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:40","pubTimestamp":1786700431,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Caribou Biosciences (CRBU), Bristol-Myers Squibb (BMY) and Schrod...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-caribou-biosciences-crbu-bristol-myers-squibb-bmy-and-schrodinger-sdgr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4007","LU0882574055.USD","LU2242646821.SGD","LU1093756325.SGD","LU0321505439.SGD","LU1670710661.SGD","SDGR","LU0237698245.USD","IHE","LU1093756168.USD","LU2242652126.USD","XBI","LU1430594728.SGD","LU0985481810.HKD","LU1983299246.USD","LU1074936037.SGD","LU2596442595.SGD","LU1585245621.USD","LU0225284248.USD","LU0267386448.USD","LU1032466523.USD","LU0096364046.USD","XLV","LU1291159041.SGD","LABU","LU1571399168.USD","LU0306807586.USD","BK4139","LU2125154778.USD","BK4539","LU2125154935.USD","BK4559","LU1261432733.SGD","IE0009355771.USD","BK4532","LU0456855351.SGD","BMY","LU1868837300.USD","LU1989771016.USD","LU1670710588.SGD","BK4588","CRBU","IE00BSNM7G36.USD","LU0321505868.SGD","HCSG","LU0868494617.USD","LU1670711040.USD","IE00B2B36J28.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659186112","title":"Analysts Offer Insights on Healthcare Companies: Kyntra Bio (KYNB) and Minerva Neurosciences (NERV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659186112","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659186112?lang=en_us&edition=fundamental","pubTime":"2026-08-14 17:00","pubTimestamp":1786698042,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kyntra Bio (KYNB) and Minerva Neurosciences (NERV). Kyntra Bio (K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kyntra-bio-kynb-and-minerva-neurosciences-nerv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kyntra-bio-kynb-and-minerva-neurosciences-nerv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","LU0029874061.USD","NERV","KYNB","HCSG","BK4137","XLV","LU0128526141.USD","BK4585","LABU","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659112995","title":"Analysts’ Top Healthcare Picks: Alcon (ALC), Kuros Biosciences (CSBTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659112995","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659112995?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:50","pubTimestamp":1786697404,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alcon (ALC) and Kuros Biosciences (CSBTF) with bulli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-alcon-alc-kuros-biosciences-csbtf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1804176565.USD","XBI","BK4581","BK4139","BK4137","LU2265009873.SGD","ALC","BK4585","BK4588","HCSG","LU0128526141.USD","BK4198","CSBTF","LU0029874061.USD","LABU","XLV","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":13,"totalSize":399,"code":"91000000","status":"200"}]}}